1 |
Beavo, J. A. and Reifsnyder, D. H. Primary sequence of cyclic nucteotide phosphodiesterase isozymes and the design of selective inhibitors. Trencls Pharmacol Sci. 1990, 11. 150-155
|
2 |
Carvajal, J. A., Germain, A. M., Huidobro-Toro, J. P. and Weiner, C. P. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiul. 2000, 184, 409-420
|
3 |
Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M.,Amano, K., Harada, K., Miyamoto, S., Nakazawa,H, Won, K. J. and Sato, K. Calcium movements, distribution, and functions in smooth muscle. Phannacol Rev. 1997, 42, 157-230
|
4 |
Lincoln, T. M. and Comwell, T. L. Intracellular cyclic GMP receptor proteins. FASEB J, 1993, 7, 328-338
|
5 |
Lugnier, C., Keravis, T. and Eckly-Michel, A. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel. J Physiol Pharmacol, 1999, 50. 639-652
|
6 |
Nakamura, T., Houchi, H., Minami, A., Sakamoto, S., Tsuchiya, K., Niwa, Y., Minakuchi, K. and Nakaya, Y. Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta. Life Sci. 2001, 69, 1709-1715
|
7 |
Perez-Vizcaino, E, Cogolludo, A. L., Zaragoza- Amaez, E, Fajardo, S., Ibarra, M., Lopez-Lopez, J. G. and Tamargo, J. Vasodilator effects of sodium nitroprusside, levcromakalim and their combination in isolated rat. Br. J. Pharmacol, 1999, 128, 1419-1426
|
8 |
Shiraishi, Y., Kanmura, Y. and Itoh, T. Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine-induced increase in [ ]i and force in middle cerebral artery of the rabbit. Br. J. Pharmacol. 1998, 123, 869-878
|
9 |
Souness, J. E., Diocee, B. K., Martin, W. and Moodie, S. A. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Biochem. J. 1990, 266, 127-132
|
10 |
Strosberg, A. D. Structure, function, and regulation of adrenergic receptors. Protein Sci. 1993, 2, 1198-1209
|
11 |
Taggart, M. J., Menice, C. B., Morgan, K. G. and Wray, S. Effect of metabolic inhibition on intracellular , Phosphorylation of myosin regulatory light chain and force in rat smooth muscle. J. Physiol. 1997, 499, 485-496
|
12 |
Tejerina, T., Sesin, J., Delgado, C. and Tamargo, J. Effect of milrinone on contractility and 45Ca movements in the isolated rabbit aorta. Eur. J. Pharmacol. 1988, 148, 239-246
|
13 |
Tomkinson, A. and Raeburn, D. The effect of isoenzyme-selective PDE inhibitors on rnethacholine- induced contraction of guinea-pig and rat ileum. Br. J. Pharmacol. 1996, 118, 2131-2139
|
14 |
Weishaar, R. E., Burrows, S. D., Kobylarz, D. C., Quade, M. M. and Evans, D. B. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets, Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem. Pharmacol. 1986, 35, 787-800
|
15 |
Lugnier, C., Keravis, T., Le Bec, A., Pauvert, O., Proteau, S. and Rinissuau, E. Characterization of cyclic nucleotide phosphodiesterase isutbrms associated to isolated cardiac nuclei. Biochim Biophys Acta. 1999, 1472, 431-446
|
16 |
Silver, P. J. Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase. Am. J. Cardiol. 1989, 63, 2A-8A
|
17 |
Shiraski, Y. and Su, C. Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur. J. Pharmacol. 1985, 114, 93-96
|
18 |
Lugnier, C., Schoeffter, P., Le Bec, A., Strouthou, E. and Stoclet, J. C. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol, 1986, 35, 1743-1751
|
19 |
Medina, P., Segarra, G., Vila, J. M., Domenech, C., Martinez-Leon, J. B. and Lluch, S. Effects of sildenafil on human penile blood vessels. Urology. 2000, 56. 539-543
|
20 |
Yu, S. M., Cheng, Z. J. and Kuo, S. C. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor. Eur. J. Pharmacol. 1995, 280, 69-77
|
21 |
Beavo, J. A. Cyclic nucleotide phosphodiesterases: func-tional implications of multiple isofumis. Physiol Rev. 1995, 75, 725-748
|
22 |
Inada, H., Shindo, H., Tawata, M. and Onaya, T. Cilostazol, a cyclic AMP phosphodiesterase inhibitor, stimulates nitric oxide production and sodium potassium adenosine triphosphatase activity in SH-SY5Y human neuroblastoma cells. Life Sci. 1999, 65, 1413-1422
|
23 |
Lincoln, T. M. Eftects of nitroprusside and 8-bromo-cyclic GMP on the contractile activity of the rat aorta. J Pharmacol Exp Ther, 1983. 224, 100-107
|
24 |
Lugnier, C. and Komas, N. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. Eur Heart J. 1993, 14(Suppl I), 141-148
|
25 |
Parson, W. J., Ramkumar. V. and Stiles, G. L. Isobutyl methylxanthine stimulates adenylate-cyclase by blocking the inhibitory regulatory protein Gi. Mol. Phannacol. 1988, 34, 37-41
|
26 |
Lincoln, T. M., Komalavilas. P. and Cornwell, T. L. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension, 1994, 23(6 Pt 2), 1141-1147
|
27 |
Medina, P., Segarra, G., Martinez-Leon, J. B., Vila, J. M., Aldasoro, M., Otero, E. and Lluch, S. Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels. Ann. Thorac. Surg. 2000, 70, 1327-1331
|
28 |
Polson, J. B. and Strada, S. J. Cyclic nucleotide phos-phodiesterases and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 1996, 36, 403-427
|
29 |
Delpy, E., Coste, H. and Gouville, A. C. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Br. J Pharmacol, 1996. 119, 471-478
|
30 |
Taira, N. Inotropic agents: new positive inotropic agents and their mechanism of action, In: Rand, MJ, Raper, C. (EDs.), Pharmacology, pp. 477-480, Elsevier, Amsterdam. 1987
|
31 |
Honerjager, P. Pharmacology of positive inotropic phos-phodiesterase Ill inhibitors. Eur Heart J, 1989, 10(Suppl C), 25-31
|
32 |
Komas, N., Lugnier, C. and Stoclet, J. C. Endothelium- dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br. J Pharmacol, 1991, 104, 495-503
|
33 |
Martin, W., Furchgott, R. E, ViBani, G. M. and Jothianandan, D. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1986, 237. 539-547
|
34 |
Ito, S., Suzuki, S. and Itoh, T. ElTects of a water-soluble forskolin derivative (NKH477) and a membrane-permeable cyclic AMP analogue on noradrenaline-induced mobilization in smooth muscle of rabbit mesenteric artery. Br. J Pharrnacol. 1993. 110, 1117-1125
|
35 |
Rapoport, R. M. Cyclic guanosine monophosphate inhibi-tion of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta. Circ. Res. 1986, 58, 407-410
|
36 |
Harrison, S. A., Chang, M. L. and Beavo, J. A. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs. Circulation, 1986, 73(3 Pt 2), III 109-116
|
37 |
Prigent, A. E, Fougier, S., Nemoz, G., Anker, G., Pacheco, H., Lugnier, C., Lebec, A. and Stoclet, J. C. Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta, Separation and inhibition by selective reference phosphodiesterase inhibitoK. Biochem. Phannacol. 1988, 37, 3671-3681
|
38 |
Nicholson, C. D., Challiss, R. A. and Shahid, M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci. 1991, 12, 19-27
|
39 |
Gray, D. W. and Marshall, I. Novel signal transduction pathway mediating endothelium-dependent beta-adre-noceptor vasorelaxation in rat thoracic aorta. Br. J Phannacol, 1992, 107, 684-690
|
40 |
van der Zypp, A., Rechtman, M. and Majewski, H. The role of cyclic nucleotides and calcium in the relaxation produced by amnnone in rat aorta. Gen. Pharmacol. 2000, 34, 245-253
|